Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-13
2009-08-25
McKane, Joseph K. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S311100
Reexamination Certificate
active
07579368
ABSTRACT:
There are presented compounds of the formulaor pharmaceutically acceptable salts thereof,wherein Y1, Y2, X1, X2, X3and R are as described in this application. These compounds are believed to inhibit MDM2-p53 interaction and as such the compounds will have anti-hyperproliferative cellular activity.
REFERENCES:
patent: 6734302 (2004-05-01), Kong et al.
patent: 7425638 (2008-09-01), Haley et al.
patent: WO 03/051359 (2003-06-01), None
patent: WO 03/051359 (2003-06-01), None
patent: WO 2005/110996 (2005-11-01), None
patent: WO 2005/123691 (2005-12-01), None
Vassilev, et. al., Science, V.303, N.5659, p. 844-848 (2004).
Fotouhi Nader
Haley Gregory Jay
Simonsen Klaus B.
Vu Binh Thanh
Webber Stephen Evan
Coppins Janet L
Hoffman-La Roche Inc.
Johnston George W.
McKane Joseph K.
Rocha-Tramaloni Patricia S.
LandOfFree
Cis-imidazolines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cis-imidazolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cis-imidazolines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4053807